Clinical Trials Sponsored by PharmaJet, Inc.

Total 35635 results

PharmaJet, Inc.

Completed

Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe

Influenza Prophylaxis

United States
PharmaJet, Inc.

Completed

Inactivated Influenza Via Jet Injection (IIJI)

Influenza, Human

United States
PharmaJet, Inc.

Completed

Jet Injection for Influenza (JIFI)

Influenza, Human

United States
PharmAkea, Inc.

Completed

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of PAT-1251 in Healthy Adult Subjects

Healthy

United Kingdom
Shire
PharmaNet; Nextrials, Inc.

Withdrawn

An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)

Leukodystrophy, Globoid Cell
Pharmanex
KGK Science Inc.

Completed

Polyphenol/Prebiotic Blend Effects on GI Health and Microbial Composition

GI Health | Microbial Composition

Canada
PharmaJet, Inc.
United States Department of Defense

Active, not recruiting

Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection

Vaccine Reaction

United States
Pharmanex

Completed

Functional Test for a Drink Powder Alone and Combined Use With a Cosmetic Apparatus

Skin Elasticity | Beauty Drink Powder | Cosmetic Apparatus on Skin | Skin Dryness | Skin Moisture | Skin Evenness | Skin Firmness

China
Pharmanex

Active, not recruiting

Inflammatory and Metabolic Responses to Long-term Dietary Supplementation With Anthocyanin-rich Blend

Anthocyanins

United States
Pharmanex

Completed

Intestinal Inflammatory and Metabolic Responses to a High Fat Meal and Plant Polyphenol Blend

Anthocyanins

United States
Pharmasset

Terminated

Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus (QUASH 1)

Hepatitis B | Chronic Hepatitis

United States, Canada, Argentina, Taiwan, Spain, Puerto Rico, Australia, Greece, Thailand, United Kingdom, Brazil, China
Pharmanex

Completed

Dietary Supplements and Personal Energy Tracking Device to Promote and Maintain Healthy Weight

Obesity | Overweight

United States
Pharmasset

Completed

A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males

HIV Infections
Fralex Therapeutics
PharmaNet

Terminated

Pain Relief Investigation of NeuroModulation Therapy in Adult Humans

Chronic Musculoskeletal Pain
Pharmanex

Completed

Beauty Image Efficacy Study

Skin Aging

China
Pharmasset

Terminated

Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus (QUASH2)

Hepatitis B | Chronic Hepatitis

United States, Canada, China, Argentina, Taiwan, Spain, Puerto Rico, Australia, Greece, Thailand, United Kingdom
Pharmasset

Completed

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

HIV Infections

United States, Argentina, Mexico, Panama
Pharmasset

Completed

A Study of DPC 817 in HIV-Infected Males

HIV Infections

United States, Germany
Pharmarte srl

Completed

Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS

Polycystic Ovary Syndrome | Hirsutism | Menstrual Problem

Italy
Pharmagest Interactive

Completed

Medico-economic Evaluation of a Telemedicine System for the Management of Chronic Renal Failure (eNephro)

Chronic Kidney Diseases

France
Bristol-Myers Squibb
PharmaNet

Completed

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting (REMAIN)

HIV

Germany, Spain, Portugal
Golden Biotechnology Corporation
PharmaNet

Completed

Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects (Hocena)

Non-small Cell Lung Cancer

Taiwan
Dr. Reddy's Laboratories Limited
PharmaNet

Completed

A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels

Type II Hyperlipidemia

Ukraine, Poland, Italy
PharmaNet
Celtic Pharma Development Services

Terminated

Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)

Peritumoral Brain Edema | PRIMARY MALIGNANT and METASTATIC BRAIN TUMORS
PharmaJet, Inc.
National Cancer Institute (NCI); National Institutes of Health (NIH)

Withdrawn

Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System

Vaccine Reaction

Indonesia
Pharmanex
Clinical Research Australia

Recruiting

Nutritional Supplement's Effects on Cognition

Healthy | Cognition | Dietary Supplement

Australia
Pharmanex
Utah State University

Completed

Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds

Healthy

United States
Pharmasset
Hoffmann-La Roche

Completed

Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin (R7128)

Healthy Volunteers | Hepatitis C Virus

United States, Puerto Rico, New Zealand
Bristol-Myers Squibb
Pharmasset

Completed

Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care

Chronic Hepatitis C

United States, Puerto Rico
Pharmanex
Nu Skin Enterprises

Completed

Effects of a Nutritional Supplement Combination on Body Weight Management

Safety/Effacy

United States
Fralex Therapeutics
PharmaNet; McDougall Scientific Limited

Terminated

Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia Population

Pain | Fibromyalgia

United States, Canada
Pharmanex
Dermatology Consulting Services, High Point NC

Completed

Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults

Skin Health

United States
Pharmanex
Utah State University

Completed

A Prospective Study Investigating the Effects of a Novel Weight Management Program

Overweight

United States
Pharmanex
University of Utah

Completed

Brain Imaging Study

Brain Health

United States
Pharmanex
Aspen Clinical Research

Completed

Effects of a Proprietary Blend of Herbal Extract Supplement on Cellular Detoxification, Inflammation, and Cumulative Cognitive Index as Well as Gene Expression in Middle-Aged Adult Women (Pharmanex)

Anti Aging

United States
Wishbone SA
EVAMED; Pharmalex; Advimago

Recruiting

Evaluation of Performance, Safety and Benefit of the Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation

Safety Issues | Bone Regeneration

Belgium
Shire
Covance; PRA Health Sciences; PharmaNet

Completed

Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy

Mucopolysaccharidosis II | Hunter Syndrome | MPS II

Brazil, Poland, Taiwan
Pharmanex
Sprim Advanced Life Sciences

Completed

Effects of a Vitality Dietary Supplement on Physical and Mental Function in Middle-aged Adults

Health-related Quality of Life

United States
Pharmanex
Dermatology Consulting Services, High Point NC

Not yet recruiting

Study to Assess Impact of Dietary Supplement on Sleep Health

Sleep
Pharmanex
Dermatology Consulting Services, High Point NC

Completed

Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults

Skin Health

United States
Bristol-Myers Squibb
inVentiv Health Clinical; PharmaNet

Completed

Long-term Experience With Abatacept SC in Routine Clinical Practice (ASCORE)

Rheumatoid Arthritis

Spain, France, Italy, United Kingdom, Greece, Australia, Austria, Germany, Monaco, Netherlands, Switzerland
Ludwig Institute for Cancer Research
Boehringer Ingelheim; MedImmune LLC; PharmaJet, Inc.; CureVac; Cancer Research Institute...

Completed

Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC

NSCLC | Metastatic Non-small Cell Lung Cancer

United States
Clarus Therapeutics, Inc.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; PharmaN...

Completed

Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

Male Hypogonadism

United States, Germany
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd

Recruiting

A Phase I Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd

Not yet recruiting

Phase I Clinical Study of BR105 Injection (BR105-I)

Advanced Malignancies

China
Pharmanex
University of North Carolina, Chapel Hill

Completed

Chronic Study on Body Composition, Training, Performance, and Recovery

Body Weight Changes | Performance Enhancing Product Use | Damage Muscle

United States
Pharmanex
University of North Carolina, Chapel Hill

Completed

Acute Study on Muscle Soreness, Damage, and Performance

Soreness, Muscle | Performance Enhancing Product Use | Damage Muscle

United States
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd

Not yet recruiting

A Phase I Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies

Advanced Malignancies

China
PharmAust Ltd
Macquarie University, Australia; Calvary Health Care Bethlehem

Recruiting

An Open Label Extension Study of Monepantel in Individuals With Motor Neurone Disease

Motor Neuron Disease

Australia
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd

Recruiting

A Phase I Study of BR108 in Hematological Malignancies

Hematologic Malignancy

China

Clinical Trials Sponsored by PharmaJet, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations